2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Metastatic Prostate Carcinoma: new trials by email Literature Review of Metastatic Prostate Carcinoma trials Research Report on Metastatic Prostate Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 3 | Completed | Mayo Clinic | 163 | 2022-05-09 | 2025-07-18 |
| Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging 3-Dimensional Conformal Radiation Therapy, Apalutamide, Computed Tomography - Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 3 | Recruiting | ECOG-ACRIN Cancer Research Group | 804 | 2020-10-08 | 2026-08-19 |
| Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Bevacizumab, Cisplatin, Gemcitabine Hydrochloride - Advanced Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 506 | 2009-07-15 | 2026-06-24 |
Prostatic Neoplasms (3) · Carcinoma, Transitional Cell (1) · Ureteral Neoplasms (1) · Urethral Neoplasms (1)
Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Prostatic Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Ureteral Diseases (1)
Magnetic Resonance Spectroscopy (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · 68Ga-DKFZ-PSMA-11 (1) · Bevacizumab (1) · Cisplatin (1) · Congresses as Topic (1) · Disulfides (1) · Gemcitabine (1) · Goserelin (1) · Immunoglobulin G (1) · Leuprolide (1) · Platinum (1) · Radiation (1) · Radiosurgery (1) · Radiotherapy, Conformal (1)
ECOG-ACRIN Cancer Research Group (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1)
United States (3) · Puerto Rico (1)
Geoffrey B. Johnson, M.D., Ph.D. (1) · Jonathan E Rosenberg (1) · Neha Vapiwala (1)
PMID 33989025, PMID 38421243, PMID 40256659, PMID 40591902
U10CA031946 (1), U10CA180820 (1), U10CA180821 (1)